Meanwhile, targeting GPX4 with its suppressor RSL3 strongly triggered ferroptosis in CRC cells with FOXA2 overexpression or chemoresistance, contributing to cell proliferation reduction. Here, FOXA2 is linked to colorectal carcinoma.